Although the present shortlisted in vivo studies reported mixed effects of serum transaminases, close to half of them observed reduced serum ALT following probiotic supplementations, implying their potential hepatoprotection properties against NAFLD-induced liver injury. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.